ArticleWorld journal of hepatology2017

Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.

Kenneth E Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.